Filing Details
- Accession Number:
- 0001640334-21-000982
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-20 16:10:56
- Reporting Period:
- 2021-04-16
- Accepted Time:
- 2021-04-20 16:10:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1621221 | Artelo Biosciences Inc. | ARTL | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1526251 | D. Gregory Gorgas | C/O Artelo Biosciences, Inc. 888 Prospect Street, Suite 210 La Jolla CA 92037 | Pres, Ceo, Cfo, Treas & Secr | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-04-16 | 8,500 | $1.15 | 270,676 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents the weighted average share price of an aggregate total of 8,500 shares purchased in the price range of $1.15 to $1.16 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.